The Effects of Cisplatin and Its PT(II) Analogue on Oxidative Stress of Isolated Rat Heart/ Efekti Cisplatine I PT(II) Analoga Cisplatine Na Oksidacioni Stres Izolovanog Srca Pacova

1. Jakupec MA, Galanski M, Keppler BK. Tumour-inhibiting platinum complexes-state of the art and future perspectives. Rev Physiol Biochem Pharmacol. 2003; 146: 1-53.10.1007/s10254-002-0001-xSearch in Google Scholar

2. Wong E, Giandomenico CM. Current Status of Platinum- Based Antitumor Drugs. Chem. Rev. 1999; 99(9): 2451-66.Search in Google Scholar

3. Desoize B, Madoulet C. Particular aspects of platinum compound used at present in cancer treatment. Crit Rev Oncol Hematol. 2002; 42(3): 317-25.10.1016/S1040-8428(01)00219-0Search in Google Scholar

4. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007; 33(1): 9-23.10.1016/j.ctrv.2006.09.006185522217084534Search in Google Scholar

5. Bugarcic ZD, Bogojeski J, Petrovic B, Hochreuther S, Eldik R. Mechanisitic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur- donor biomolecules. Dalton Trans. 2012; 41(40): 12329-45.10.1039/c2dt31045g22890549Search in Google Scholar

6. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014; 740: 364-78.10.1016/j.ejphar.2014.07.025414668425058905Search in Google Scholar

7. Schimmel KJM, Richel DJ, Van Den Brink RBA, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004; 30(2): 181-91.10.1016/j.ctrv.2003.07.00315023436Search in Google Scholar

8. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin Nephrotoxicity: A Review. The Am J Med Sci. 2007; 334(2): 115-24.10.1097/MAJ.0b013e31812dfe1e17700201Search in Google Scholar

9. Miller PR, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin Nephrotoxicty. Toxins. 2010; 2(11): 2490-518.10.3390/toxins2112490315317422069563Search in Google Scholar

10. Mc Whinney SR, Goldberg RM, Mc Leod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther. 2009; 8(1): 10-6.10.1158/1535-7163.MCT-08-0840265182919139108Search in Google Scholar

11. Ding D, Allman BL, Salvi R. Review: Ototoxic Characteristics of Platinum Antitumor Drugs. Anat Rec (Hoboken). 2012; 295(11): 1851-67.10.1002/ar.2257723044998Search in Google Scholar

12. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 2009; 61(3): 223-42. 10.1016/j.etp.2008.09.003Search in Google Scholar

13. Döring HJ, Dehnert H. The isolated perfused warmblooded heart according to Langendorff. In: Döring C (Ed.): Methods in Experimental Physiology and Pharmacology. Biological Measurement Techniques. Berlin, Germany: Biomesstechnik-Verlag, 1988: pp. 1-129Search in Google Scholar

14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2): 351-8.10.1016/0003-2697(79)90738-3Search in Google Scholar

15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982; 126(1): 131-8.10.1016/0003-2697(82)90118-XSearch in Google Scholar

16. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenvvald Ra Hadnbook of methods for oxygen radical research. CRC Press Une, Boca Raton. 1985: 123-32.Search in Google Scholar

17. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J immunol Methods. 1980: 38(1-2); 161-70.10.1016/0022-1759(80)90340-3Search in Google Scholar

18. Jordan P, Carmo-Fonesca M. Molecular mechanisms invoved in cisplatin cytotoxicity. Cell Mol. Life Sci. 2000; 57(8-9): 1229-35.10.1007/PL00000762Search in Google Scholar

19. Arola OJ, Saraste A, Pulkki K et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000; 60(7): 1789-92.Search in Google Scholar

20. Icli F, Karaouguz H, Dincol D et al. Sever vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 1993; 72(2): 587-93.10.1002/1097-0142(19930715)72:2<587::AID-CNCR2820720242>3.0.CO;2-VSearch in Google Scholar

21. Dieckmann KP, Struss WJ, Budde U. Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour. Anticancer res. 2011; 31(12): 4501-6.Search in Google Scholar

22. Galanski M, Keppler BK. Synthesis and characterization of new ethylendiamine platinum(IV) complexes containg lipophilic carboxylate ligands. Metal Based Drugs. 1995; 2: 57-63. 10.1155/MBD.1995.57Search in Google Scholar

23. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents. Drug Saf. 2000; 22(4): 263-302.10.2165/00002018-200022040-00002Search in Google Scholar

24. Ferroni P, Della-Monte D, Palmirotta R et al. Platinumbased compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention. Rejuventation Res. 2011; 14(3): 293-308.10.1089/rej.2010.1141Search in Google Scholar

25. Al-Majed AA, Sayed-Ahmed AA, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. Propionyl-L-carnitine prevents the progression of cisplatin-induces cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res. 2010; 53(3): 278-86.10.1016/j.phrs.2005.12.005Search in Google Scholar

26. Ma H, Jones KR, Guo R, Xu P, Shan Y, Ran J. Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: role of endoplasmic reticulum stress. Clin. Exp. Pharmacol. Physiol. 2010; 37(4): 460-5.Search in Google Scholar

27. Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol. 2009; 47(6): 1176-83.10.1016/j.fct.2009.02.007Search in Google Scholar

28. Damian G. Deavall, Elizabeth A.Martin, Judith M. Horner, and Ruth Roberts. Drug-Induced Oxidative Stress and Toxicity. J Toxicol. 2012; 1-13.10.1155/2012/645460Search in Google Scholar

29. Yuce A, Atessahin A, Ceribasi AO, Aksakal M. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin Pharmacol Toxicol. 2007; 101(5): 345-9.10.1111/j.1742-7843.2007.00129.xSearch in Google Scholar

30. El-Sawalhi MM, Ahmed LA. Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, In cisplatin-induced cardiotoxicityin rats. Chem Biol Interact.2014; 207: 58-66.10.1016/j.cbi.2013.11.008Search in Google Scholar

31. Hussein A, Ahmed AAE, Shouman SA, Sharawy S. Ameliorating effect of DL-α-lipoic acid against cisplatin- induced nephrotoxicity and cardiotoxicity in experimental animals. Drug Discov Ther. 2012; 6(3): 147-56.10.5582/ddt.2012.v6.3.147Search in Google Scholar

32. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003; 142(3): 178-86.10.1016/S0022-2143(03)00111-2Search in Google Scholar

33. Sawicka E, Długosz A, Jedrzejczyk J. Antioxidative Enzyme Activities after Exposure to KP972 and Cisplatin. Adv Clin Exp Med 2011; 591-7.Search in Google Scholar

34. Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, Enli Y. The effects of desferrioxamine on cisplatin induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 2004; 23(1): 29-/34.10.1191/0960327104ht413oa15027813Search in Google Scholar

35. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical Mechanisms of Cisplatin Cytotoxicity. Anticanc Anticancer Agents Med Chem. 2007; 7(1): 3-18.10.2174/18715200777931404417266502Search in Google Scholar

36. Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol. 2008; 28(3): 337-44.Search in Google Scholar

37. Ko JW, Lee IC, Park SH. Protective effects of pine bark extract against cisplatininduced hepatotoxicity andoxidative stress in rats. Lab Anim Res. 2014; 30(4): 174-80.10.5625/lar.2014.30.4.174430670525628728Search in Google Scholar

38. Antunes LMG, Darin JDC, Bianchi MDL. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dosedependent study. Pharmacol Res. 2000; 41(4): 406-11.Search in Google Scholar

39. Ciftci O, Ozdemir I, Vardi N, Gurbuz N. Novel platinum- N-heterocyclic carbine complex is more cardiotoxic than cis-platin in rats. Hum Exp Toxicol. 2010; 30(9): 1342-9 10.1177/096032711039006421075807Search in Google Scholar